Nanocrystalline Silver Technology
Nucryst Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology.
Nucryst has a successful nanocrystalline silver coating business and is developing a pipeline of potential products to target diseases involving infection and/or inflammation.
8/8/07 NUCRYST Pharmaceuticals announces 2007 second quarter results MORE >
8/1/07 NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Second Quarter Results MORE >

8/8/07 NUCRYST Pharmaceuticals 2007 second quarter results webcast, MORE >

To be notified by email of upcoming events and press releases MORE >